InMed Pharmaceuticals
11 hedge funds and large institutions have $981K invested in InMed Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.01% less ownership
Funds ownership: 0.02% → 0.01% (-0.01%)
15% less funds holding
Funds holding: 13 → 11 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
67% less capital invested
Capital invested by funds: $2.99M → $981K (-$2.01M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$27.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7.15K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$5.96K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$906K |
| 2 |
PCM
Penserra Capital Management
Orinda,
California
|
-$49K |
| 3 |
Morgan Stanley
New York
|
-$2.38K |
| 4 |
RFA
Reilly Financial Advisors
La Mesa,
California
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $893K | -$906K | -760 | -43% |
|
|
2
Citadel Advisors
Miami,
Florida
| $31K | +$5.96K | +5 | +16% |
|
|
VF
3
Virtu Financial
New York
| $20K | +$27.4K | +23 | New |
|
4
Creative Planning
Overland Park,
Kansas
| $19K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $9K | +$7.15K | +6 | +150% |
|
6
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $3K | – | – | – |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $2K | – | – | – |
|
|
AWM
8
AllSquare Wealth Management
Albany,
New York
| $1K | – | – | – |
|
|
FF
9
FourThought Financial
Venice,
Florida
| $1K | – | – | – |
|
|
NWM
10
Navigation Wealth Management
Fort Collins,
Colorado
| $1K | – | – | – |
|
|
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $894 | – | – | – |
|
|
PCM
12
Penserra Capital Management
Orinda,
California
| – | -$49K | -40 | Closed |
|
|
13
Morgan Stanley
New York
| – | -$2.38K | -2 | Closed |
|
|
RFA
14
Reilly Financial Advisors
La Mesa,
California
| – | -$2K | -1 | Closed |
|
INM Hedge Fund Activity: Q3 2021 in Review
11 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in InMed Pharmaceuticals (INM) for Q3 2021, worth a combined $981K — down 67% from $2.99M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of INM and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $27.4K. The largest seller was Armistice Capital, cutting an estimated $906K.
- 11 institutional investors held InMed Pharmaceuticals (INM) as of Q3 2021, down from 13 in Q2 2021.
- Funds reported $981K of InMed Pharmaceuticals stock for Q3 2021, down 67% quarter-over-quarter.
- 1 fund opened new InMed Pharmaceuticals positions in Q3 2021 and 3 closed out, a net change of -2 holders.
- The largest InMed Pharmaceuticals buyer in Q3 2021 was Virtu Financial, an estimated $27.4K added.
- The largest InMed Pharmaceuticals seller in Q3 2021 was Armistice Capital, an estimated $906K sold.
Based on aggregated 13F filings for Q3 2021.